This paper explores the economic incentives for medical procedure innovation. Using a proprietary dataset on billing code applications for emerging medical procedures, we highlight two mechanisms that could hinder innovation. First, the administrative hurdle of securing permanent, reimbursable...

While Australia has enjoyed the benefits of a National Medicines Policy (NMP) for many years, there is no national equivalent policy for medical devices. This is despite an established medical device legal framework that spans multiple departments across the Australian Government. The existing...

Scholars and policymakers across the ideological spectrum agree that the U.S. drug pricing system is deeply flawed. Most reform proposals focus on one symptom: high prices for existing drugs. But high prices aren’t all that ails the U.S. drug pricing system: Current law also provides weak...

Intro -- DOCTORING MEDICAL GOVERNANCE: MEDICAL SELF-REGULATION IN TRANSITION -- CONTENTS -- PREFACE -- DEDICATION -- INTRODUCTION -- FROM ANCIENT BEGINNINGS TO THE 1858 MEDICAL ACT -- Ancient Beginnings -- Galen's Humors -- Galenic Medicine and the Christian Worldview -- The Enlightenment and...

This paper studies the impact of the first effective medical treatment for an infectious disease -diphtheria antitoxin- on the historical health transition in the United States. Using an instrumental variable for local antitoxin adoption rates and information from approximately 1.6 million death...